Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242586983> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4242586983 endingPage "2833" @default.
- W4242586983 startingPage "2827" @default.
- W4242586983 abstract "A high remission rate is achieved with high-dose melphalan (HDM) in multiple myeloma (MM), and autologous transplantation of hematopoietic stem cells allows a prompt hematologic recovery after high-dose therapy. We treated 97 patients with high-risk MM (group 1:44 advanced MM including 14 primary resistances and 30 relapses; group 2: 53 newly diagnosed MM) with a first course of HDM. For responding patients a second course of high-dose therapy with hematopoietic stem cell support was proposed. After the first HDM, the overall response and complete remission rates were 71% and 25% with no significant difference between the two groups. The median durations of neutropenia and thrombocytopenia were significantly longer in group 1 (29.5 days and 32 days, respectively) than in group 2 (23 days and 17 days, respectively). This severe myelosuppression led to eight toxic deaths and the fact that only 38 of the 69 responders could proceed to the second course (three allogenic and 35 autologous transplantations). Among the 35 patients undergoing autologous transplantation (10 in group 1, 25 in group 2), 31 received their marrow unpurged collected after the first HDM, and four received peripheral blood stem cells. The median durations of neutropenia and thrombocytopenia after autologous transplantation were 24 days and 49 days, respectively. Two toxic deaths and nine prolonged thrombocytopenias were observed. The median survival for the 97 patients was 24 months (17 months in group 1, 37 months in group 2) and the median duration of response was 20 months. The only parameters that have a significant impact on the survival are the age (+/- 50 years) and the response to HDM. The median survival of the 35 patients undergoing autologous transplantation is 41 months, but the median duration of remission is 28 months with no plateau of the remission duration curve. Patients responding to HDM may have prolonged survival, but even a second course of high-dose therapy probably cannot eradicate the malignant clone." @default.
- W4242586983 created "2022-05-12" @default.
- W4242586983 creator A5024396025 @default.
- W4242586983 creator A5024819951 @default.
- W4242586983 creator A5029315909 @default.
- W4242586983 creator A5034473496 @default.
- W4242586983 creator A5037324033 @default.
- W4242586983 creator A5039256171 @default.
- W4242586983 creator A5041108107 @default.
- W4242586983 creator A5066046718 @default.
- W4242586983 creator A5071589084 @default.
- W4242586983 creator A5083829407 @default.
- W4242586983 date "1992-06-01" @default.
- W4242586983 modified "2023-10-15" @default.
- W4242586983 title "Double-intensive therapy in high-risk multiple myeloma" @default.
- W4242586983 doi "https://doi.org/10.1182/blood.v79.11.2827.bloodjournal79112827" @default.
- W4242586983 hasPublicationYear "1992" @default.
- W4242586983 type Work @default.
- W4242586983 citedByCount "75" @default.
- W4242586983 countsByYear W42425869832012 @default.
- W4242586983 countsByYear W42425869832015 @default.
- W4242586983 countsByYear W42425869832016 @default.
- W4242586983 countsByYear W42425869832018 @default.
- W4242586983 countsByYear W42425869832020 @default.
- W4242586983 crossrefType "journal-article" @default.
- W4242586983 hasAuthorship W4242586983A5024396025 @default.
- W4242586983 hasAuthorship W4242586983A5024819951 @default.
- W4242586983 hasAuthorship W4242586983A5029315909 @default.
- W4242586983 hasAuthorship W4242586983A5034473496 @default.
- W4242586983 hasAuthorship W4242586983A5037324033 @default.
- W4242586983 hasAuthorship W4242586983A5039256171 @default.
- W4242586983 hasAuthorship W4242586983A5041108107 @default.
- W4242586983 hasAuthorship W4242586983A5066046718 @default.
- W4242586983 hasAuthorship W4242586983A5071589084 @default.
- W4242586983 hasAuthorship W4242586983A5083829407 @default.
- W4242586983 hasBestOaLocation W42425869831 @default.
- W4242586983 hasConcept C126322002 @default.
- W4242586983 hasConcept C141071460 @default.
- W4242586983 hasConcept C2776364478 @default.
- W4242586983 hasConcept C2776694085 @default.
- W4242586983 hasConcept C2777063308 @default.
- W4242586983 hasConcept C2777408962 @default.
- W4242586983 hasConcept C2778684742 @default.
- W4242586983 hasConcept C2779050716 @default.
- W4242586983 hasConcept C2911091166 @default.
- W4242586983 hasConcept C71924100 @default.
- W4242586983 hasConcept C90924648 @default.
- W4242586983 hasConceptScore W4242586983C126322002 @default.
- W4242586983 hasConceptScore W4242586983C141071460 @default.
- W4242586983 hasConceptScore W4242586983C2776364478 @default.
- W4242586983 hasConceptScore W4242586983C2776694085 @default.
- W4242586983 hasConceptScore W4242586983C2777063308 @default.
- W4242586983 hasConceptScore W4242586983C2777408962 @default.
- W4242586983 hasConceptScore W4242586983C2778684742 @default.
- W4242586983 hasConceptScore W4242586983C2779050716 @default.
- W4242586983 hasConceptScore W4242586983C2911091166 @default.
- W4242586983 hasConceptScore W4242586983C71924100 @default.
- W4242586983 hasConceptScore W4242586983C90924648 @default.
- W4242586983 hasIssue "11" @default.
- W4242586983 hasLocation W42425869831 @default.
- W4242586983 hasOpenAccess W4242586983 @default.
- W4242586983 hasPrimaryLocation W42425869831 @default.
- W4242586983 hasRelatedWork W19571804 @default.
- W4242586983 hasRelatedWork W20342555 @default.
- W4242586983 hasRelatedWork W20936464 @default.
- W4242586983 hasRelatedWork W22273718 @default.
- W4242586983 hasRelatedWork W22610400 @default.
- W4242586983 hasRelatedWork W2646510 @default.
- W4242586983 hasRelatedWork W3221457 @default.
- W4242586983 hasRelatedWork W3657330 @default.
- W4242586983 hasRelatedWork W7322239 @default.
- W4242586983 hasRelatedWork W8870890 @default.
- W4242586983 hasVolume "79" @default.
- W4242586983 isParatext "false" @default.
- W4242586983 isRetracted "false" @default.
- W4242586983 workType "article" @default.